###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
SGS1 is a multicopy suppressor of srs2: functional overlap between DNA helicases
###end article-title 0
###begin p 1
To whom correspondence should be addressed. Tel: +44 151 794 5333; Fax: +44 151 794 5337; Email: amorgan@liv.ac.uk
###end p 1
###begin p 2
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1srs2</italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 492 496 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 612 616 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 621 625 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 653 657 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 667 671 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 719 723 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 823 827 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 849 853 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 905 909 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1075 1079 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1102 1106 1074 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1190 1194 1162 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1266 1270 1234 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
Sgs1 is a member of the RecQ family of DNA helicases, which have been implicated in genomic stability, cancer and ageing. Srs2 is another DNA helicase that shares several phenotypic features with Sgs1 and double sgs1srs2 mutants have a severe synthetic growth phenotype. This suggests that there may be functional overlap between these two DNA helicases. Consistent with this idea, we found the srs2Delta mutant to have a similar genotoxin sensitivity profile and replicative lifespan to the sgs1Delta mutant. In order to directly test if Sgs1 and Srs2 are functionally interchangeable, the ability of high-copy SGS1 and SRS2 plasmids to complement the srs2Delta and sgs1Delta mutants was assessed. We report here that SGS1 is a multicopy suppressor of the methyl methanesulphonate (MMS) and hydroxyurea sensitivity of the srs2Delta mutant, whereas SRS2 overexpression had no complementing ability in the sgs1Delta mutant. Domains of Sgs1 directly required for processing MMS-induced DNA damage, most notably the helicase domain, are also required for complementation of the srs2Delta mutant. Although SGS1 overexpression was unable to rescue the shortened mean replicative lifespan of the srs2Delta mutant, maximum lifespan was significantly increased by multicopy SGS1. We conclude that Sgs1 is able to partially compensate for the loss of Srs2.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c1">1</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c2">2</xref>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c3">3</xref>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RECQ4</italic>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c4">4</xref>
###xml 714 717 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c5">5</xref>
###xml 1022 1023 1022 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c6">6</xref>
###xml 1063 1071 1063 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 1073 1074 1073 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c7">7</xref>
###xml 1088 1089 1088 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c8">8</xref>
###xml 1283 1284 1283 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c9">9</xref>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 1120 1128 <span type="species:ncbi:9606">patients</span>
The ability of DNA helicases to unwind DNA enables replication, transcription, recombination and repair of DNA. The fundamental importance of DNA helicases is highlighted by a variety of human genetic disorders resulting from defective helicase function (1). Although the clinical features of these disorders differ, they all exhibit genomic instability and a predisposition to cancer. One class of DNA helicases, the RecQ family (named after its homology with the prototypical bacterial RecQ helicase), has attracted particular interest recently (2). Defects in three of the five known human RecQ family members manifest as Bloom's syndrome (BLM) (3), Rothmund-Thomson syndrome (RECQ4) (4) and Werner's syndrome (WRN) (5). All three disorders show genomic instability associated with a predisposition to various cancers, while Rothmund-Thomson syndrome and Werner's syndrome display features of premature ageing. At the cellular level, cells from Werner's syndrome sufferers display genomic translocations and deletions (6), and a decreased replicative lifespan in vitro (7, reviewed in 8). Cells from Bloom's syndrome patients similarly exhibit chromosomal rearrangements and deletions, but are characterised by a uniquely high frequency of sister chromatid exchanges (reviewed in 9).
###end p 4
###begin p 5
###xml 190 206 190 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 208 232 208 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 237 262 237 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 386 397 386 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli recQ</italic>
###xml 399 416 399 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae SGS1</italic>
###xml 421 433 421 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe rqh1</italic>
###xml 433 434 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>+</sup></italic>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 677 680 677 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c12">12</xref>
###xml 743 747 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c12">12</xref>
###xml 918 921 918 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c12">12</xref>
###xml 1009 1011 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c22">22</xref>
###xml 1020 1024 1020 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1258 1260 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c25">25</xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 190 206 <span type="species:ncbi:562">Escherichia coli</span>
###xml 208 232 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 237 262 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 386 392 <span type="species:ncbi:562">E.coli</span>
###xml 399 411 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 421 428 <span type="species:ncbi:4896">S.pombe</span>
###xml 617 622 <span type="species:ncbi:4932">yeast</span>
###xml 663 668 <span type="species:ncbi:9606">human</span>
###xml 912 917 <span type="species:ncbi:9606">human</span>
In order to shed light on how mutations in human RecQ helicases result in genomic instability, much recent attention has been directed at RecQ orthologues in lower organisms. The genomes of Escherichia coli, Saccharomyces cerevisiae and Schizosaccharomyces pombe each contain only a single predicted RecQ helicase, thus facilitating analysis of their cellular function(s). Mutations in E.coli recQ, S.cerevisiae SGS1 and S.pombe rqh1+ all result in increased recombination (10-15), suggesting a conserved role of RecQ helicases in regulating recombination. Interestingly, the hyper-recombination phenotype of budding yeast sgs1 mutants can be complemented by the human WRN and BLM genes (12). In addition to the hyper-recombination phenotype, sgs1 mutants are sensitive to a range of genotoxins and display a reduced replicative lifespan (defined as the number of buds produced by a mother cell) (12,16-24). The human BLM gene has been shown to complement the hydroxyurea sensitivity (12) and short lifespan (22) of the sgs1 mutant, further reinforcing the notion of a conserved function of RecQ helicases. Current thinking suggests that this function may be the prevention of inappropriate recombination at stalled replication forks arising during S phase (25).
###end p 5
###begin p 6
###xml 4 21 4 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae SRS2</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad6</italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad18</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c26">26</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c27">27</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c28">28</xref>
###xml 388 395 388 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c29">29</xref>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD6</italic>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c30">30</xref>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD52</italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c31">31</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c32">32</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c33">33</xref>
###xml 4 16 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 188 193 <span type="species:ncbi:4932">yeast</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 388 395 <span type="species:ncbi:4896">S.pombe</span>
The S.cerevisiae SRS2 gene was discovered as a suppressor of the UV sensitivity of rad6 and rad18 mutants (26), and also independently in a genetic screen which isolated and characterised yeast hyper-recombination mutants (27). No obvious human homologue of Srs2 has yet been found, but the sequence of the SRS2 gene does show homology to the bacterial UvrD and Rep helicases (28) and an S.pombe orthologue has been identified recently (29). One function of Srs2 is to channel the repair of DNA lesions into the RAD6 post-replication repair pathway (30). In the absence of Srs2, DNA lesions are instead channelled into the RAD52 homologous recombination repair pathway (31). Srs2 has also been implicated in other DNA repair processes such as non-homologous end joining (32) and single-strand annealing (33).
###end p 6
###begin p 7
###xml 126 134 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 136 138 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c34">34</xref>
###xml 139 141 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c35">35</xref>
###xml 148 152 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 157 161 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 342 344 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c18">18</xref>
###xml 345 347 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c36">36</xref>
###xml 348 350 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c37">37</xref>
###xml 366 370 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 375 379 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 426 428 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c13">13</xref>
###xml 429 431 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c27">27</xref>
###xml 449 453 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 463 467 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 618 619 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 637 639 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 663 667 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 672 676 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 773 774 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 888 890 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c20">20</xref>
###xml 891 893 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 894 896 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c39">39</xref>
###xml 975 983 965 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1srs2</italic>
Srs2 shares a number of interesting features with Sgs1. Both Sgs1 and Srs2 have been demonstrated to be 3'-->5' DNA helicases in vitro (34,35). The SGS1 and SRS2 gene products are generally expressed at low abundance but are up-regulated during the S phase of the cell cycle, and both have been implicated in the intra-S checkpoint response (18,36,37). Furthermore, sgs1 and srs2 mutants have a hyper-recombination phenotype (13,27). Most recently, sgs1Delta and srs2Delta strains have both been shown to have a shortened replicative lifespan and a greater propensity to undergo terminal cell-cycle arrest as mitotic G2/M intermediates (38). Deletion of both the SGS1 and SRS2 genes causes a severe synthetic growth defect, with low cell viability and a high incidence of G2/M terminal cell-cycle arrest, which can be suppressed by deletion of genes involved in homologous recombination (20,38,39). This suggests that unrestrained recombination causes the poor growth of the sgs1srs2 double mutant and is consistent with the idea that Srs2, like Sgs1, may act to prevent inappropriate recombination at stalled replication forks.
###end p 7
###begin p 8
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c40">40</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c20">20</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c40">40</xref>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 532 536 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 585 589 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 672 676 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
It was initially proposed that the Sgs1 and Srs2 helicases perform redundant functions in DNA replication and RNA pol I transcription (40). However, the DNA replication and RNA pol I defects reported are in fact likely to be secondary consequences of unrestrained recombination (20). Nevertheless, the original suggestion of functional overlap between these two helicases (40) remains possible. Consistent with this idea, we found the srs2Delta mutant to have a similar genotoxin sensitivity profile and replicative lifespan to the sgs1Delta mutant. Moreover, increased gene dosage of SGS1 partially restored genotoxin resistance and increased the maximum lifespan in the srs2Delta mutant. This indicates that Sgs1 can partially compensate for the loss of Srs2.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains and plasmids
###end title 10
###begin p 11
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf202tb1">1</xref>
###xml 312 325 312 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains and plasmids used in this study are described briefly in Table 1. The BY4743 strain was obtained from ATCC (Manassas, TN), and all other strains were obtained from Research Genetics (Groningen, The Netherlands). All deletion mutants were prepared by deletion module PCR using the Kan MX4 cassette (Saccharomyces Genome Deletion Project).
###end p 11
###begin p 12
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD3</italic>
The pYES2 vector was obtained from Invitrogen (Groningen, The Netherlands). The pQE30 plasmid was obtained from Qiagen (Dorking, UK). The YCplac33 and YEplac195 vectors were gifts from Dr Alan Boyd (University of Edinburgh, Edinburgh, UK). The pNF3000 plasmid, which carries the RAD3 gene controlled by its endogenous promoter in the YEp24 vector, was generously provided by Drs Paula Fischaber and Errol Friedberg (University of Texas Southwestern Medical Center, Dallas, TX).
###end p 12
###begin title 13
Plasmid construction
###end title 13
###begin p 14
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 262 268 262 268 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 326 332 326 332 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGTACC</underline>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 422 425 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 454 457 454 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 572 576 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 623 629 623 629 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 661 664 661 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 692 698 692 698 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTCGAG</underline>
###xml 734 737 734 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 791 794 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 801 804 801 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 823 826 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 829 832 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 179 184 <span type="species:ncbi:4932">yeast</span>
The YCplac33-SRS2 and YEplac195-SRS2 plasmids were constructed as follows. The 3525 bp SRS2 open reading frame (ORF) plus 610 bp upstream and 132 bp downstream was amplified from yeast genomic DNA (Promega, Southampton, UK) using the following primers: CATGAACCTGGATCCATATATAGAAATCGG (sense, BamHI site underlined) and CATTAAGGGTACCTAACACACCATCCACATTTC (antisense, KpnI site underlined). The PCR product was digested with BamHI and KpnI and ligated into BamHI/KpnI-digested YCplac33 and YEplac195 vectors. The pYES2-SRS2 plasmid was constructed by amplifying the 3.525 kb SRS2 ORF from YEplac195-SRS2 using the primers GGGAGGATCCATGTCGTCGAACAATGATCTTTG (sense, BamHI site underlined) and GAAACTCGAGCTAATCGATGACTATGATTTCAC (antisense, XhoI site underlined). The PCR product was digested with BamHI and XhoI and ligated into BamHI/XhoI-digested pYES2 vector.
###end p 14
###begin p 15
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 93 96 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 122 126 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 146 150 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 164 168 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 170 173 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 179 181 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 188 191 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 223 227 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 279 283 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 351 357 347 353 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 379 382 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 410 416 406 412 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTCGAG</underline>
###xml 449 452 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 506 509 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 516 519 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 538 541 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 544 547 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 293 298 <span type="species:ncbi:4932">yeast</span>
The YEplac195-SGS1 and YEplac195-SGS1 K706-->A constructs were made by subcloning the 4.8 kb SalI fragment containing the SGS1 gene from YCplac33-SGS1 and YCplac33-SGS1 K706-->A (23) into SalI-digested YEplac195. The pYES2-SGS1 plasmid was constructed by amplifying the 4.344 kb SGS1 ORF from yeast genomic DNA using the following primers: GTACACACAAGGGATCCATGGTGACGAAGC (sense, BamHI site underlined) and TTTCCTCGAGTCACTTTCTTCCTCTGTAGT (antisense, XhoI site underlined). The PCR product was digested with BamHI and XhoI and ligated into BamHI/XhoI-digested pYES2 vector.
###end p 15
###begin p 16
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 160 166 160 166 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 222 228 222 228 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGTACC</underline>
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
The pQE30-SGS1(1-400) plasmid was constructed as follows. The 1200 bp fragment of SGS1 was amplified from YCplac33-SGS1 using the following primers: GTACACACAAGGGATCCATGGTGACGAAGC (sense, BamHI site underlined) and TTCTTCTGGTACCACCTACGGATAATCGTC (antisense, KpnI site underlined). The PCR product was digested with BamHI and KpnI and ligated into BamHI/KpnI-digested pQE30 plasmid.
###end p 16
###begin title 17
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
Construction of SGS1 mutant libraries
###end title 17
###begin p 18
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 307 315 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 338 340 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c41">41</xref>
###xml 369 377 360 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 412 415 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 595 601 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 661 662 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 666 667 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 741 742 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R</sup>
###xml 795 798 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1011 1014 992 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1057 1065 1038 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1099 1105 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1124 1125 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 595 601 <span type="species:ncbi:562">E.coli</span>
###xml 1099 1105 <span type="species:ncbi:562">E.coli</span>
Initially, the YEplac195-SGS1 plasmid was modified to remove a NotI restriction site carried over from the original cloning vector. Transposon-based mutagenesis was then performed on this modified plasmid using the E::Ztrade mark In-frame linker insertion kit (Cambio, Cambridge, UK). This utilises the Tn5 in vitro transposition system (41). Mutagenesis was performed in vitro by incubating 0.03 pmol of EZ::TN<NotI/KAN-3> transposon and plasmid DNA with 1 microl of Tn5 transposase enzyme at 37degreesC for 2 h. The reaction was then stopped and the reaction mixture transformed into XL1 Blue E.coli (Stratagene, Amsterdam, The Netherlands). All resultant Kan+ Amp+ colonies were pooled and grown up prior to plasmid DNA isolation. The KanR gene was spliced out by digesting the midiprep with NotI, leaving a 57-bp sequence at the site of transposon insertion. This sequence codes for a 19-amino acid read-through insertion, which maintains the reading frame and so avoids creation of truncation mutants. The NotI-cut plasmid was gel purified, re-ligated in vitro and re-transformed into XL1 Blue E.coli. The resulting Amp+ colonies were used to construct both the random mutational library and the methyl methanesulphonate (MMS) loss-of-function library.
###end p 18
###begin p 19
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 407 410 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
For the random mutational library, 190 Amp+ colonies were selected at random and grown up individually. Of these, PCR analysis identified 80 colonies that contained plasmids harbouring the 57-bp insertion within the SGS1 gene. These colonies were individually grown up prior to isolation of their plasmid DNA. The position of transposon insertion was determined by digesting plasmid minipreps with SalI and NotI.
###end p 19
###begin p 20
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 221 222 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 358 362 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 378 382 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 398 402 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 660 664 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 856 862 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 877 878 855 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 856 862 <span type="species:ncbi:562">E.coli</span>
For the MMS loss-of-function library, all original Amp+ colonies harbouring transposon-mutagenised YEplac195-SGS1 were pooled and grown up. Their DNA was then isolated and transformed into the sgs1Delta mutant strain. Ura+ transformants (500) were then picked and patched individually onto 10 x 10 grids on SD-URA plates. Each plate also contained positive (sgs1Delta-YEplac195-SGS1) and negative (sgs1Delta-YEplac195) controls for comparison. Plates were incubated overnight at 30degreesC, and then replica plated onto plates containing 0.023% MMS and left for 2 days. Loss-of-function mutations (i.e. plasmids no longer able to rescue MMS sensitivity in the sgs1Delta strain) were identified on replica plates, and the corresponding colonies picked from the master plate. These were grown up, pooled and their DNA recovered and transformed into XL1 Blue E.coli. Forty-two Amp+ colonies were selected for further analysis of transposon insertion by restriction digest analysis. The remaining colonies were pooled, and their DNA isolated by midiprep.
###end p 20
###begin title 21
Drug sensitivity plates
###end title 21
###begin p 22
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 95 97 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 568 571 558 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 172 177 <span type="species:ncbi:4932">yeast</span>
###xml 535 540 <span type="species:ncbi:4932">yeast</span>
This was performed as described previously for sgs1Delta, using identical drug concentrations (23). For quantitation of strains grown on solid media supplemented with MMS, yeast strains were grown up in minimal media for 2-3 days at 30degreesC, diluted and then spread on solid media plates containing increasing doses of MMS. After 3 days, the percent viability of each strain was expressed as number of colonies obtained relative to that on the control (no MMS) plate. For quantitation of MMS sensitivity of strains in liquid media, yeast strains were grown to an OD600 of 0.5-0.6 before addition of 0.01-0.12% MMS for 60 min. Cells were washed in 10% sodium thiosulfate, diluted and spread onto solid media plates. After 3 days, the percent viability of each strain was expressed as number of colonies obtained relative to that obtained for the control samples.
###end p 22
###begin title 23
Detection of Sgs1 and Srs2 by western blotting
###end title 23
###begin p 24
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c42">42</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 259 265 <span type="species:ncbi:562">E.coli</span>
###xml 408 415 <span type="species:ncbi:9986">rabbits</span>
###xml 621 625 <span type="species:ncbi:9925">goat</span>
Yeast extracts were prepared by bead-beating in 8 M-urea-containing 2D-gel extraction buffer (Bio-Rad, Hemel Hempstead, UK) and run on SDS-polyacrylamide gels prior to transfer onto nitrocellulose. Recombinant his-tagged Sgs1(1-400) protein was purified from E.coli transformed with the pQE30-SGS1(1-400) plasmid using Ni2+-NTA-agarose (Qiagen). The purified protein was then used for antibody production in rabbits by following a published method (42). The resulting Sgs1p 857 antiserum was then purified using protein G-Sepharose to yield the IgG fraction used for western blotting. The Srs2p (yA-19) and Sir2p (yN-19) goat polyclonal antibodies were obtained from Autogen Bioclear (Mile Elm, UK). All primary antibodies were routinely used at dilutions of 1:500. Immunoreactive bands were detected with peroxidase-conjugated secondary antisera and visualised using enhanced chemiluminescence.
###end p 24
###begin title 25
Lifespan analysis
###end title 25
###begin p 26
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 115 118 109 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 342 347 <span type="species:ncbi:4932">yeast</span>
This was performed as described previously (23). Briefly, strains were grown at 30degreesC until they reached an OD600 of 0.6-1.0. One microlitre of culture was streaked onto plates and left at 30degreesC for 1-2 h. After this time, cell doublets were moved to uninhabited regions of the plate. When these budded again, (newly formed) virgin yeast cells were removed by micromanipulation to a new location. All future buds produced by these daughter cells were micromanipulated away, and catalogued. The plates were incubated at 30degreesC during working hours, and moved to 4degreesC overnight. Lifespan was defined as number of daughter cells removed from the mother cell. All lifespans were observed a minimum of twice.
###end p 26
###begin title 27
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast transformation and DNA extraction
###end title 27
###begin p 28
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
This was performed as described previously (23).
###end p 28
###begin title 29
RESULTS
###end title 29
###begin p 30
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 213 217 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 275 279 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 382 383 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f1">1</xref>
###xml 482 484 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 553 554 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 589 590 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 605 609 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 719 723 695 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 793 797 765 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 862 863 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 889 891 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 991 995 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1005 1009 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1024 1026 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 1052 1056 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1060 1064 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
Deletion of the SGS1 gene in both haploid and diploid strains has been reported to result in a replicative lifespan of approximately40% that of isogenic wild-type strains (22-24). To determine whether deletion of SRS2 has a similar effect, lifespan analysis was performed on srs2Delta and BY4743 (wild-type) isogenic diploid strains transformed with the empty YCplac33 vector (Fig. 1A). Both strains were transformed with YCplac33 to allow direct comparison with previous findings (23). The mean lifespan of the BY4743-YCplac33 strain was 16.0 +/- 1.0 (n = 76), compared with 7.2 +/- 0.9 (n = 38) for the srs2Delta-YCplac33 strain. The maximum lifespans recorded were 44 and 23, respectively. The short lifespan of the srs2Delta mutant observed is comparable with that of the isogenic diploid sgs1Delta-YCplac33 strain, which has a mean lifespan of 7.4 +/- 0.8 (n = 32) and maximum of 16 (23). A similar magnitude of shortened replicative lifespan has recently been reported for the haploid sgs1Delta and srs2Delta strains (38). Therefore, deletion of SGS1 or SRS2 reduces the replicative lifespan to a similar extent in both haploid and diploid backgrounds.
###end p 30
###begin p 31
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 298 300 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 336 340 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 381 385 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 456 460 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 564 568 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 604 608 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 623 627 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 690 691 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f1">1</xref>
###xml 710 714 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 732 736 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 824 828 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 864 868 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 1002 1006 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 1104 1108 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 1140 1144 1108 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
We have previously characterised the sensitivity of the sgs1Delta mutant to MMS (DNA methylating agent), 4-NQO (causes bulky-base adducts and oxidative damage), hydroxyurea (DNA synthesis inhibitor), camptothecin (Type I topoisomerase inhibitor) and mitoxantrone (Type II topoisomerase inhibitor) (23). To assess the sensitivity of the srs2Delta mutant to these drugs, the diploid srs2Delta mutant was transformed with YCplac33 (empty vector) and YCplac33-SRS2 and compared with the BY4743 isogenic wild-type strain transformed with YCplac33. Various dilutions of srs2Delta-YCplac33, BY4743-YCplac33 and srs2Delta-YCplac33-SRS2 strains were grown on plates containing the above drugs (Fig. 1B). Similar to the sgs1Delta mutant, the srs2Delta-YCplac33 strain showed sensitivity to all DNA damaging agents tested. Transformed srs2Delta cells containing the YCplac33-SRS2 plasmid showed comparable drug sensitivity to the BY4743 wild-type strain under these conditions. The observation that plasmid-borne SRS2 can restore genotoxin resistance to isogenic wild-type levels thus confirms that deletion of the SRS2 gene is the sole defect in the srs2Delta mutant.
###end p 31
###begin p 32
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 79 83 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 181 185 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
###xml 192 196 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rrm3</italic>
###xml 203 208 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yKU70</italic>
###xml 218 223 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yKU80</italic>
###xml 350 352 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c43">43</xref>
###xml 431 433 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c44">44</xref>
###xml 440 441 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 441 445 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KU70</italic>
###xml 450 451 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 451 455 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KU80</italic>
###xml 538 540 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c45">45</xref>
###xml 643 645 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c46">46</xref>
###xml 646 648 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c47">47</xref>
###xml 673 677 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
###xml 778 782 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rrm3</italic>
###xml 789 794 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yKU70</italic>
###xml 804 809 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yKU80</italic>
###xml 127 132 <span type="species:ncbi:4932">yeast</span>
To assess the specificity of the drug sensitive phenotype of the sgs1Delta and srs2Delta strains, the MMS sensitivity of other yeast mutants lacking DNA helicases was assessed. The pif1Delta, rrm3Delta, yKU70Delta and yKU80Delta mutants were tested. Pif1 and Rrm3 are DNA helicases involved in regulating telomeric and mitochondrial DNA (reviewed in 43), and are also involved in the replication fork progression through the rDNA (44). The yKU70 and yKU80 gene products are involved in the repair of DNA double strand breaks (reviewed in 45) and physical and genetic interactions between RecQ helicases and Ku proteins have been demonstrated (46,47). It was found that the pif1Delta mutant showed a slight sensitivity to MMS, as compared with the isogenic wild-type strain. The rrm3Delta, yKU70Delta and yKU80Delta strains were not sensitive to MMS (results not shown). Therefore, MMS sensitivity appears to be a relatively specific phenotype for loss-of-function of either the Sgs1 or Srs2 helicases.
###end p 32
###begin p 33
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c40">40</xref>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vivo</italic>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 455 459 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 471 475 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 477 481 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 497 501 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 513 517 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 727 731 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 743 747 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 757 761 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 796 797 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f2">2</xref>
###xml 882 886 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 898 902 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 912 916 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 951 952 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f2">2</xref>
Based on the fact that either single mutant is viable, but the double mutant has a severe growth defect, it has been proposed that the Sgs1 and Srs2 helicases may be functionally redundant (40). We therefore reasoned that overexpression of either of these DNA helicases might compensate for loss of the other. To initially confirm overexpression, Sgs1 and Srs2 levels in vivo were assessed by western blotting. Protein was extracted from sgs1Delta-pYES2, sgs1Delta-pYES2-SGS1, srs2Delta-pYES2 and srs2Delta-pYES2-SRS2 cultures induced with galactose. Extracted protein samples were separated by SDS-PAGE, western blotted and probed for either Sgs1 or Srs2. An approximately160 kDa band corresponding to Sgs1 was present in the sgs1Delta-pYES2-SGS1, but not sgs1Delta-pYES2, protein extract (Fig. 2A). Similarly, an approximately150 kDa band corresponding to Srs2 was present in the srs2Delta-pYES2-SRS2, but not srs2Delta-pYES2, protein extract (Fig. 2A). For a control, all samples were probed for Sir2p, which was equally present in all protein extracts.
###end p 33
###begin p 34
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c11">11</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c48">48</xref>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top3</italic>
###xml 554 558 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TOP3</italic>
###xml 582 586 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top3</italic>
###xml 711 715 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 731 732 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f2">2</xref>
###xml 764 765 756 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 825 829 817 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 855 859 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 861 864 853 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 934 938 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 954 955 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1033 1037 1023 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top3</italic>
###xml 1180 1184 1166 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top3</italic>
###xml 1367 1371 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top3</italic>
###xml 1526 1528 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c11">11</xref>
###xml 1529 1531 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c48">48</xref>
Although expression of SGS1 or SRS2 from the galactose-inducible pYES2 vector resulted in detectable levels of Sgs1 or Srs2 protein, it was not possible to detect Sgs1 by western blotting when SGS1 was expressed under its own promoter from the YEplac195 vector. We therefore attempted to genetically verify the overexpression of Sgs1 from this plasmid. Sgs1 helicase activity has been postulated to produce a substrate that is deleterious unless resolved by Top3 (11,48). Sgs1 overexpression should therefore be more harmful in top3Delta mutants than in TOP3 strains. To test this, top3Delta mutant and isogenic wild-type control strains were transformed with both low-copy (YCplac33) and high-copy (YEplac195) SGS1 plasmids (Fig. 2B). Both strains gave viable Ura+ transformants when transformed with the YCplac33, YCplac33-SGS1, YEplac195 and YEplac195-SGS1 K706-->A plasmids. However, transformation of both strains with YEplac195-SGS1 gave viable Ura+ transformants in the wild-type strain, but very few viable colonies with the top3Delta mutant. Therefore, expression of Sgs1 from the multicopy YEplac195 vector, but not the low-copy YCplac33 plasmid, was detrimental to the top3Delta mutant. This indicates that increased gene dosage of Sgs1 does indeed result in increased Sgs1 protein levels. Furthermore, the deleterious effects of higher Sgs1 levels in the top3Delta mutant required the helicase activity of Sgs1, consistent with the notion that the helicase activity of Sgs1 creates a substrate that Top3 resolves (11,48).
###end p 34
###begin p 35
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 165 169 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 203 204 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf202tb2">2</xref>
###xml 310 314 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD3</italic>
###xml 369 371 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c49">49</xref>
###xml 495 499 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
###xml 564 568 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 585 589 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 600 604 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 657 661 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 727 731 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 740 744 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
###xml 845 849 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 856 860 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
###xml 918 922 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 934 938 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 949 953 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1011 1015 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1025 1029 987 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1055 1059 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
###xml 1143 1147 1097 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1149 1152 1103 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 1242 1246 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1261 1263 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 1264 1266 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c50">50</xref>
###xml 1320 1324 1268 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1333 1337 1277 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1534 1540 1474 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad3-1</italic>
###xml 1549 1551 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c49">49</xref>
To assess if Sgs1 and Srs2 are functionally interchangeable, the ability of high-copy plasmids carrying SGS1 and SRS2 to rescue MMS sensitivity in the sgs1Delta and srs2Delta strains was assessed (Table 2). To control for non-specific effects of helicase overexpression, the high-copy pNF3000 plasmid carrying RAD3 (a 5'-->3' DNA helicase involved in excision repair) (49) was also compared. As a further specificity control, the effects of these plasmids on the (slight) MMS sensitivity of the pif1Delta mutant were also investigated. High-copy plasmids encoding SRS2 (both YEplac195-SRS2 and pYES2-SRS2) were able to complement the MMS sensitivity of the srs2Delta mutant, but had no obvious beneficial effects in either the sgs1Delta or pif1Delta mutants. Rather, Srs2 overexpression was found to have a dominant negative effect on growth of sgs1Delta, pif1Delta and wild-type strains. High-copy vectors expressing SGS1 (YEplac195-SGS1 and pYES2-SGS1) were able to complement the MMS sensitivity of both the sgs1Delta and srs2Delta mutant, but not the pif1Delta mutant. Sgs1 helicase activity was essential for complementation as YEplac195-SGS1 K706-->A (expressing a helicase-defective allele which has some complementing activity in the sgs1Delta mutant) (23,50) was not able to suppress the MMS sensitivity of the sgs1Delta or srs2Delta mutant. The pNF3000 plasmid was unable to rescue the MMS sensitivity of all three mutants tested, although this plasmid has been demonstrated previously to complement the UV sensitivity of a rad3-1 strain (49).
###end p 35
###begin p 36
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 112 113 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f3">3</xref>
###xml 154 158 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 195 199 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 338 342 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 362 366 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 389 393 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 409 413 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 415 419 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 769 773 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 819 823 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 923 924 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f3">3</xref>
###xml 1047 1048 1011 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f3">3</xref>
###xml 1094 1098 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1191 1195 1155 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
The ability of SGS1 to rescue the sensitivity of the srs2Delta mutant to MMS and hydroxyurea is shown in Figure 3A. This demonstrates that the ability of SGS1 to act as a multicopy suppressor of srs2Delta is not uniquely specific for sensitivity to DNA damaging agents, but is also seen for inhibitors of DNA replication. To quantify the SGS1 complementation of srs2Delta MMS sensitivity, srs2Delta-YEplac195-SGS1, srs2Delta-YEplac195 and BY4743-YEplac195 diploid strains were grown up, diluted and then spread onto plates containing increasing doses of MMS. After 3 days, the percent viability of each strain was expressed as number of colonies obtained relative to that on the control (no MMS) plate. It can be seen that at the 0.003% dose, where complete killing of srs2Delta-YEplac195 cells occurred, the YEplac195-SGS1 construct restored MMS resistance to approximately60% of that seen in the isogenic wild-type (Fig. 3B). A similar effect was observed when cells were exposed to MMS for 1 h before removal and inactivation of the drug (Fig. 3C). Under these conditions, overexpression of SGS1 restored viability to 30-40% of wild-type levels at doses where complete killing of control srs2Delta-YEplac195 cells occurred.
###end p 36
###begin p 37
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c21">21</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c51">51</xref>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 357 361 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 404 412 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 462 466 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 511 515 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 797 801 789 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 815 816 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f4">4</xref>
###xml 900 904 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1030 1034 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1150 1154 1142 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1248 1252 1240 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1267 1271 1255 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1366 1370 1350 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1392 1393 1376 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1860 1861 1844 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f4">4</xref>
###xml 2024 2026 2008 2010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 2027 2029 2011 2013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c51">51</xref>
###xml 2037 2038 2021 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f4">4</xref>
Mutational analysis suggests that Sgs1 is a multifunctional protein, as mutant alleles of sgs1 have selective complementing ability in different phenotypic assays (17,21,23,51). We therefore set out to determine whether the domains of Sgs1 required for rescue of MMS sensitivity in the sgs1Delta mutant differ from those required for complementation of the srs2Delta mutant. In order to do this, we used in vitro transposon-scanning mutagenesis on the YEplac195-SGS1 plasmid to create two distinct libraries of sgs1 mutants containing in-frame 19-amino acid insertions (see Materials and Methods). The unselected mutational library was generated by individually growing up randomly chosen bacterial colonies and PCR screening for the presence of plasmids harbouring the 57-bp insertion within the SGS1 gene. Figure 4A shows the frequency and approximate location of in-frame transposon insertions in SGS1 in this library, which comprises 75 alleles. It can be seen that there is coverage of insertion events throughout the entire SGS1 gene with no obvious hotspots, suggesting that transposon insertion is basically random. To construct a library of sgs1 MMS loss-of-function plasmids (i.e. plasmids no longer able to rescue MMS sensitivity in the sgs1Delta strain), sgs1Delta cells were transformed with the entire original pool of transposon-mutagenised YEplac195-SGS1. Of the resulting Ura+ transformants, 500 were picked and grown up individually on 10 x 10 grids before replica plating onto MMS plates. One hundred colonies failed to grow on MMS plates; these were recovered from the master plate, and their pooled plasmid DNA isolated to create the MMS loss-of-function library. Restriction analysis of 42 alleles chosen at random from this library revealed a more restricted distribution of insertion events than in the unselected library (compare Fig. 4A and B). Most notably, there was a complete absence of insertions in the C-terminal 250 amino acids of Sgs1, a domain known to be dispensable for MMS resistance (17,51) (Fig. 4B).
###end p 37
###begin p 38
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 113 117 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 176 180 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 207 208 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 253 257 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 348 352 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 386 387 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f4">4</xref>
###xml 407 408 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 544 548 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 596 600 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 788 792 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 817 823 801 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 867 871 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 939 943 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 997 1001 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1063 1067 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1115 1119 1091 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1129 1133 1101 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
To determine whether the same functional domains of SGS1 are also required for complementation of srs2Delta, the srs2Delta mutant was transformed with the MMS loss-of-function SGS1 library (more than 500 Ura+ transformants obtained). For a control, the srs2Delta mutant was also transformed with the unselected library of 75 transposon-mutagenised SGS1 plasmids characterised in Figure 4A (more than 200 Ura+ transformants obtained). Colonies were resuspended, diluted and spread on control (no MMS) and 0.0035% MMS plates (a dose at which the srs2Delta mutant fails to grow). For the unselected SGS1 plasmid library, 156 colonies were obtained in total, compared with 378 colonies obtained on the control (no MMS) plates. This verifies that insertion of the 57-bp linker sequence in the SGS1 gene is not detrimental per se. In contrast, for the MMS loss-of-function SGS1 plasmid library, none of the MMS loss-of-function plasmids (in the sgs1Delta background) could rescue MMS sensitivity in the srs2Delta mutant. Therefore, we conclude that the same domains of SGS1 are required to restore MMS resistance to both sgs1Delta and srs2Delta strains, suggesting that a common molecular mechanism of action underlies complementation in both mutants.
###end p 38
###begin p 39
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 108 110 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c28">28</xref>
###xml 335 339 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 377 381 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 473 477 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 487 491 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 674 678 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 688 692 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 748 749 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f5">5</xref>
###xml 777 779 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c28">28</xref>
###xml 794 798 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 851 855 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 958 962 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 978 982 940 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 998 1002 956 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 1018 1022 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
It has been reported that sensitivity to MMS is enhanced in diploid srs2Delta strains relative to haploids (28). This ploidy-specific phenotype has been interpreted as additional lethal recombination events occurring between homologous chromosomes as well as sister chromatids. We therefore set out to determine whether the ability of SGS1 to complement MMS sensitivity in the srs2Delta mutant is due to suppression of recombination between homologous chromosomes. Haploid sgs1Delta and srs2Delta strains were used for these studies and compared with the isogenic wild-type BY4741 strain. To directly compare any ploidy-specific phenotypes, both haploid and diploid BY4741, sgs1Delta and srs2Delta mutant strains were grown on plates +/- MMS (Fig. 5A). As reported previously (28), the diploid srs2Delta strain was more MMS sensitive than the haploid srs2Delta strain. The observed MMS sensitivity of strains (in order of most MMS sensitive) was as follows: srs2Delta diploid > sgs1Delta haploid = sgs1Delta diploid > srs2Delta haploid > BY4741 haploid = BY4741 diploid.
###end p 39
###begin p 40
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 170 174 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 222 226 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 246 250 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 364 365 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f5">5</xref>
###xml 394 398 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 418 422 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 424 427 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 490 494 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 504 508 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 552 556 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 613 617 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 670 674 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 740 744 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 790 794 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
To test for any ploidy-specific effects of Sgs1 and Srs2 overexpression, haploid strains transformed with YEplac195, YEplac195-SGS1, YEplac195-SGS1 K706-->A or YEplac195-SRS2 were grown on plates +/- MMS. Both the haploid sgs1Delta-YEplac195 and srs2Delta-YEplac195 strains were sensitive to 0.01% MMS, whereas BY4741-YEplac195 was unaffected at these doses (Fig. 5B). The ability of YEplac195-SGS1 (and not YEplac195-SGS1 K706-->A) to suppress MMS sensitivity was reproducible in both the sgs1Delta and srs2Delta haploid strains. Similarly, YEplac195-SRS2 could rescue the MMS-sensitive phenotype of the haploid srs2Delta mutant, but again no beneficial effects in the sgs1Delta haploid were evident. This demonstrates that the ability of SGS1 to function as a multicopy suppressor of the srs2Delta mutant is not a ploidy-specific effect.
###end p 40
###begin p 41
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 212 216 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 236 240 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 256 260 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 275 276 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f6">6</xref>
###xml 411 412 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 423 427 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 461 462 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 473 477 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 493 497 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 581 582 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 668 669 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 716 718 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c52">52</xref>
###xml 801 805 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 821 822 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In addition to the MMS-sensitive phenotype, the ability of the YEplac195-SGS1 plasmid to rescue the shortened replicative lifespan of the srs2Delta mutant was investigated. Lifespan analysis was performed on the srs2Delta-YEplac195 and srs2Delta-YEplac195-SGS1 strains (Fig. 6). Average lifespans of the strains [expressed as mean number of buds removed +/- standard error of the mean (SEM)] were 11.1 +/- 1.2 (n = 37) for srs2Delta-YEplac195 and 13.3 +/- 1.4 (n = 38) for srs2Delta-YEplac195-SGS1. The maximum lifespans recorded were 24 and 36, respectively. Although a Student's t-test revealed there to be no significant difference between the mean lifespans, a chi2 test on the 10% longest-lived subpopulations (52) revealed that Sgs1 overexpression caused a statistically significant increase in srs2Delta lifespan (P < 0.02).
###end p 41
###begin title 42
DISCUSSION
###end title 42
###begin title 43
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 41 45 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
Phenotypic overlap between sgs1Delta and srs2Delta mutants
###end title 43
###begin p 44
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c13">13</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c18">18</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c27">27</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c37">37</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 255 257 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c12">12</xref>
###xml 258 260 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c16">16</xref>
###xml 261 263 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 264 266 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c19">19</xref>
###xml 267 269 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 296 300 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 439 443 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 503 507 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 584 588 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 754 758 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 778 780 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 851 855 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 865 869 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
Mutant sgs1 and srs2 strains have been shown to exhibit hyper-recombination, defective intra-S checkpoint responses and shortened replicative lifespans (13,18,27,37,38). The sgs1Delta mutant is also known to be sensitive to a variety of genotoxic agents (12,16,17,19,23). We report here that the srs2Delta mutant is similarly sensitive to MMS, hydroxyurea, camptothecin, mitoxantrone and 4-NQO, reinforcing the phenotypic overlap with the sgs1Delta mutant. In addition to its genotoxin sensitivity, the sgs1Delta mutant has a shortened replicative lifespan (22-24). We found that the srs2Delta mutant has a mean replicative lifespan approximately45% of that of the wild-type strain. This is comparable with the average lifespan recorded for the isogenic sgs1Delta mutant (43%) (23), revealing a similar magnitude of shortened lifespan for the diploid sgs1Delta and srs2Delta mutants.
###end p 44
###begin p 45
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 109 113 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 128 130 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 225 229 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 270 272 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c24">24</xref>
###xml 369 373 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 383 387 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 505 507 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 546 547 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 654 660 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 662 664 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 874 878 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 888 892 868 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1088 1094 1064 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1096 1098 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 1128 1136 1104 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1srs2</italic>
###xml 1274 1276 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
These findings are in agreement with a recent report documenting the phenotypes of the haploid sgs1Delta and srs2Delta mutants (38). In that work, it was revealed that the previous characterisation of premature ageing in the sgs1 mutant as a phenocopy of normal ageing (24) was not entirely accurate. Instead, it was concluded that the short lifespan exhibited by both sgs1Delta and srs2Delta mutants was due to a combination of ageing-independent mitotic checkpoint arrest and accelerated normal ageing (38). To determine whether the increased G2/M checkpoint arrest phenotype was also apparent in our diploid strains, we followed the approach of McVey et al. (38) and re-analysed our lifespan data for incidence of terminally budded phenotypes. This analysis was performed blind as our lifespan studies were completed before publication of their report. The morphology of sgs1Delta and srs2Delta terminal phenotypes revealed a higher percentage of budded mitotic intermediates than that observed for the isogenic wild-type strain (data not shown), thus confirming the findings of McVey et al. (38). As the severe phenotype of sgs1srs2 double mutants can be suppressed by inactivation of Rad51, Rad52 or Rad57, it is likely that it results from unrestrained recombination (38), in keeping with the idea that both Sgs1 and Srs2 act to prevent such events during S phase.
###end p 45
###begin title 46
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 43 47 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
Complementation of the srs2Delta mutant by SGS1
###end title 46
###begin p 47
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c40">40</xref>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 599 603 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 658 662 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 908 910 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c53">53</xref>
It has been suggested that the Sgs1 and Srs2 helicases may be functionally redundant, based on the fact that either single mutant is viable, but the double mutant has a severe growth defect (40). Although complete redundancy can be ruled out due to the abundance of phenotypes exhibited by each single mutant (see above), the similarities of these phenotypes are consistent with a degree of functional overlap. Our finding that SGS1 can function as a multicopy suppressor of the MMS and hydroxyurea sensitivity of the srs2Delta mutant provides direct support for this notion. In contrast, high-copy SRS2 was unable to complement genotoxin sensitivity of the sgs1Delta strain. One explanation of this finding is that Sgs1 performs some cellular function(s) that cannot be substituted by Srs2, despite the ability of Sgs1 to functionally replace Srs2. However, it is worth noting that, as reported previously (53), we found that higher levels of Srs2 caused detrimental effects in the wild-type strain.
###end p 47
###begin p 48
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c11">11</xref>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c50">50</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c51">51</xref>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 445 449 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 514 518 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 662 666 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 751 755 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 877 879 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 880 882 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c21">21</xref>
###xml 883 885 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c23">23</xref>
###xml 886 888 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c51">51</xref>
###xml 889 891 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c58">58</xref>
###xml 1110 1112 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 1232 1234 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c57">57</xref>
###xml 1375 1377 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c17">17</xref>
###xml 1378 1380 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c51">51</xref>
###xml 1415 1419 1403 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1474 1478 1462 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1568 1570 1552 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c50">50</xref>
###xml 1616 1620 1600 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1680 1684 1660 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1710 1714 1686 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
Sgs1 is a large protein that, in addition to the RecQ helicase domain, has distinct domains required for interactions with Top2, Top3 and Rad51 (11,54-57). Furthermore, mutant alleles of sgs1 have selective complementing ability in different phenotypic assays (17,23,50,51). Therefore, the domains of Sgs1 required for rescue of MMS sensitivity in the sgs1Delta background could potentially differ from those required for complementation of the srs2Delta mutant. To address this issue, we constructed libraries of SGS1 mutant plasmids containing small in-frame insertions. Unsurprisingly, a large proportion of loss-of-function mutants for MMS resistance in the sgs1Delta background contained transposon insertions in or around the helicase domain of SGS1. This is consistent with reports that the helicase activity of Sgs1 is required for dealing with MMS-induced DNA damage (17,21,23,51,58). Some insertions were also found N-terminal to the helicase domain, mapping close to the interaction sites for Top2 and Top3. This supports the observation that the N-terminus of Sgs1 is essential for MMS resistance (17). Interestingly, no MMS loss-of-function alleles mapped to the C-terminus of Sgs1, where the Rad51 interaction occurs (57). Again, this is consistent with reports that much of the C-terminus of Sgs1 (the final 254 amino acids) is dispensable for MMS resistance (17,51). It was found that none of these SGS1 loss-of-function plasmids tested could complement the srs2Delta mutant. Similarly, a point mutation causing inactivation of Sgs1 helicase activity (50) was unable to restore MMS resistance to the srs2Delta strain. This demonstrates that complementation of the srs2Delta mutant by high-copy SGS1 requires domains of Sgs1 that are directly involved in processing MMS-induced DNA lesions.
###end p 48
###begin p 49
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 159 163 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 214 218 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 385 389 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 444 448 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 597 601 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 658 662 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 693 697 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 761 763 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c18">18</xref>
###xml 764 766 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c24">24</xref>
###xml 778 782 762 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 810 814 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 900 904 880 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 992 996 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
When SGS1 was over expressed in the srs2Delta mutant, no significant increase in the mean replicative lifespan was evident. This contrasts with the ability of SGS1 overexpression to suppress MMS sensitivity of the srs2Delta mutant. One possible reason for this is that other important roles of Srs2 may still be lacking and contribute to the shortened mean replicative lifespan of the srs2Delta mutant. Alternatively, the beneficial effects of SGS1 overexpression may be outweighed by detrimental effects associated with high levels of Sgs1. Several observations support the latter theory. First, SGS1 overexpression can increase the maximum lifespan of the srs2Delta mutant by 50%. Secondly, SGS1 overexpression has been reported to cause detrimental effects (18,24). Thirdly, srs2Delta cells over expressing SGS1 actually show an increase in terminally budded morphologies as compared with control srs2Delta mutants containing empty vector (data not shown). It is remarkable that high-copy SGS1 can extend maximum lifespan in the face of such deleterious effects.
###end p 49
###begin title 50
Cellular functions of Sgs1 and Srs2
###end title 50
###begin p 51
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c59">59</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c2">2</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c57">57</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c60">60</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f7">7</xref>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 590 594 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
Proteins involved in recombinational repair (e.g. Rad52) and post-replication repair (e.g. Rad6 and Rad18) play important roles in processing DNA lesions induced by MMS, in an analogous manner to that proposed for the processing of UV-induced lesions (59). Srs2 is thought to channel lesions into post-replication repair pathways, whereas Sgs1 is thought to be more intimately involved in recombinational repair (2,57,60) (Fig. 7). The ability of Sgs1 overexpression to process MMS-induced DNA damage in the srs2Delta mutant implies that endogenous Sgs1 levels are normally limiting in the srs2Delta mutant. This effect of Sgs1 overexpression may be to increase the efficiency of Sgs1's normal physiological function(s), thereby reducing the requirement for Srs2-dependent repair pathways. Alternatively, it may be that Sgs1 is capable of directly replacing Srs2, by processing substrates that would normally be dealt with by Srs2.
###end p 51
###begin p 52
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 60 64 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 130 132 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c20">20</xref>
###xml 174 179 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD51</italic>
###xml 183 188 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD52</italic>
###xml 235 239 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 253 255 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c61">61</xref>
###xml 284 289 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD51</italic>
###xml 293 298 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD52</italic>
###xml 335 339 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 353 355 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c62">62</xref>
###xml 458 460 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c31">31</xref>
###xml 555 556 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf202f7">7</xref>
###xml 735 737 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c63">63</xref>
###xml 933 935 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c57">57</xref>
###xml 936 938 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c64">64</xref>
###xml 1017 1019 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c14">14</xref>
###xml 1101 1109 1085 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1srs2</italic>
###xml 1126 1128 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c40">40</xref>
###xml 1204 1206 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c20">20</xref>
###xml 1207 1209 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c38">38</xref>
###xml 1210 1212 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c39">39</xref>
A variety of data support the notion that the sgs1Delta and srs2Delta phenotypes are a consequence of unrestrained recombination (20). Consistent with this, mutations in the RAD51 or RAD52 genes can suppress the MMS sensitivity of the srs2Delta mutant (61), whereas overexpression of RAD51 or RAD52 enhances the MMS sensitivity of the srs2Delta mutant (62). Therefore, in the absence of Srs2, the Rad52-dependent recombination repair pathway is over-active (31), leading to aberrant processing of recombination intermediates and genomic instability (Fig. 7). However, it is worth noting that, in addition to its well-established anti-recombinase function, Srs2 has recently been claimed to promote recombination in some circumstances (63). The absence of Sgs1 would also be predicted to cause aberrant processing of recombination intermediates as not only are the later steps of the homologous recombination repair pathway impaired (57,64), but also aberrant recombination intermediates cannot be 'salvaged' by Sgs1 (14). This model is consistent with observations that the synthetic growth defect in sgs1srs2 double mutants (40) can be rescued by mutation of genes involved in homologous recombination (20,38,39).
###end p 52
###begin p 53
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 440 452 436 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe srs2</italic>
###xml 457 461 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rqh1</italic>
###xml 482 484 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c29">29</xref>
###xml 544 553 532 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1/rqh1</italic>
###xml 553 554 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 553 554 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>+</sup></italic>
###xml 559 563 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 754 758 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rqh1</italic>
###xml 758 759 746 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 758 759 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>+</sup></italic>
###xml 793 805 781 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe srs2</italic>
###xml 440 447 <span type="species:ncbi:4896">S.pombe</span>
###xml 793 800 <span type="species:ncbi:4896">S.pombe</span>
Although we favour the idea that Sgs1 overexpression rescues MMS sensitivity in the srs2Delta mutant by suppressing unrestrained recombination, it remains possible that the ability of Sgs1 overexpression to compensate for lack of Srs2 is unrelated to DNA recombination. This possibility is supported by the fact that inactivation of the homologous recombination pathway does not suppress the severe synthetic growth defects observed in the S.pombe srs2Deltarqh1Delta double mutant (29). Nevertheless, the fact that genetic interactions between SGS1/rqh1+ and SRS2 are evident in two such evolutionarily divergent species further supports the notion of functional overlap between these DNA helicases. It will be of interest to assess if overexpression of rqh1+ can rescue any phenotypes of the S.pombe srs2Delta mutant.
###end p 53
###begin title 54
Wider implications of functional overlap between DNA helicases
###end title 54
###begin p 55
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c65">65</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c66">66</xref>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ku70</italic>
###xml 762 772 762 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dmblm</italic>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf202c47">47</xref>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 762 772 <span type="species:ncbi:7227">Drosophila</span>
###xml 882 887 <span type="species:ncbi:9606">human</span>
###xml 1049 1054 <span type="species:ncbi:9606">human</span>
These findings may have potentially important ramifications for studies of the human RecQ helicases. First, the physiological effects of overexpression of Sgs1 may warrant further characterisation, as higher levels of both the BLM and WRN helicases have been reported to exist in transformed cells and tumour cells, relative to those found in normal cells (65,66). Furthermore, the finding that RecQ helicases can show partial functional redundancy with other DNA repair pathways may be significant for the understanding of the functions of RecQ family members in maintenance of genomic stability. In addition to the functional overlap between Sgs1 and Srs2 demonstrated here, an extra copy of Ku70, a DNA repair helicase, can partially rescue the phenotypes of Drosophila lacking the RecQ helicase Dmblm (47). This functional overlap of DNA repair pathways implies that defects in human RecQ helicases would have more severe effects under conditions where the redundant pathways are limiting. This may be important in understanding the role of the human RecQ helicases in genomic stability, cancer and ageing.
###end p 55
###begin title 56
Figures and Tables
###end title 56
###begin p 57
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 100 101 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 126 130 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 656 657 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 719 723 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 746 747 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 813 814 795 796 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1103 1106 1079 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 1150 1154 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1170 1174 1142 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1182 1186 1150 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1201 1205 1165 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 1207 1211 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1216 1221 1176 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-SRS2</italic>
###xml 1221 1222 1181 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 497 502 <span type="species:ncbi:4932">yeast</span>
 The diploid srs2Delta mutant has a shortened replicative lifespan and is sensitive to genotoxins. (A) Lifespan analysis. The srs2Delta and isogenic wild-type BY4743 diploid strains were transformed with YCplac33 vector and the replicative lifespan determined manually by micromanipulation. Individual cells were followed until they ceased dividing, and replicative age was defined as the number of buds removed from a mother cell. The survivorship curve shows the percentage of the population of yeast cells that is viable plotted against replicative age. Average lifespan of the strains (expressed as mean number of buds removed +/- SEM) was 16 +/- 1.0 (n = 76) for the BY4743-YCplac33 strain and 7.2 +/- 0.9 for the srs2Delta-YCplac33 strain (n = 38). Maximum lifespans recorded were 44 and 23, respectively. (B) Genotoxin sensitivity. Strains were grown up, diluted and serially spotted out onto solid media plates containing various drugs. Plates were left for 3-4 days at 30degreesC. Cell spots (from left to right) correspond to serial 1 in 10 dilutions of cells (starting, furthest left, with OD600 = 0.33). The diploid strains compared were srs2Delta-YCplac33 (srs2Delta), srs2Delta-YCplac33-SRS2 (srs2Delta-SRS2+) and the wild-type control, BY4743-YCplac33 (BY4743). Drug doses used were as follows: 50 mM hydroxyurea, 0.33 mM camptothecin, 0.0066% MMS, 1 mM mitoxantrone and 0.5 microM 4-NQO.
###end p 57
###begin p 58
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo.</italic>
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 197 201 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 213 217 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 219 223 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 239 243 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 255 259 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 460 461 444 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 485 488 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT</italic>
###xml 488 489 472 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 489 493 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top3</italic>
###xml 608 612 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 707 711 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 734 738 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 753 757 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 759 762 739 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 950 951 922 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 330 335 <span type="species:ncbi:4932">Yeast</span>
 Confirming overexpression of the Sgs1 and Srs2 helicases in vivo. (A) The ability to detect Sgs1 and Srs2 in vivo was assessed by western blotting. Protein was extracted from the sgs1Delta-pYES2, sgs1Delta-pYES2-SGS1, srs2Delta-pYES2 and srs2Delta-pYES2-SRS2 strains incubated in galactose-containing media to induce expression. Yeast proteins were extracted, separated by SDS-PAGE and probed for Sgs1 or Srs2. For control, the samples were probed for Sir2. (B) Transformation of the MATatop3Delta mutant and isogenic wild-type control BY4742 strains with both low-copy (YCplac33) and high-copy (YEplac195) SGS1 plasmids was compared. Both strains were transformed with equal amounts of YCplac33, YCplac33-SGS1, YEplac195, YEplac195-SGS1 and YEplac195-SGS1 K706-->A plasmids. Equivalent amounts of each transformation mixture were spread on SD-URA solid media plates and incubated at 30degreesC. After 3 days, plates were assessed for numbers of Ura+ transformants.
###end p 58
###begin p 59
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 81 82 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 96 100 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 500 501 486 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 519 523 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 554 558 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 890 894 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 911 915 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 923 927 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 943 947 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 949 953 919 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 959 963 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 963 964 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1129 1130 1093 1094 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1148 1152 1112 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1184 1188 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1577 1581 1537 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1598 1602 1554 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1610 1614 1562 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1630 1634 1578 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1636 1640 1584 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 1646 1650 1590 1594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1650 1651 1594 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1304 1309 <span type="species:ncbi:4932">yeast</span>
SGS1 is a multicopy suppressor of the drug sensitivity of the srs2Delta mutant. (A) The diploid srs2Delta mutant was transformed with a range of constructs subcloned into the high-copy vector, YEplac195. Strains were grown up in minimal media, then diluted and serially spotted out onto control (no drug) plates and plates containing either 0.0062% MMS or 50 mM hydroxyurea. Plates were left at 30degreesC for 3 days. Cell spots (from left to right) correspond to serial 1 in 10 dilutions of cells. (B) To quantify the srs2Delta-complementing ability of SGS1, strains were grown up as above and then spread onto plates containing increasing doses of MMS. The number of colonies visible after 3 days was then counted on each plate. For each strain, percent viability was expressed as a percentage of viable colonies obtained on the control (no MMS) plates. The diploid strains compared were srs2Delta-YEplac195 (srs2Delta), srs2Delta-YEplac195-SGS1 (srs2Delta-SGS1+) and the isogenic wild-type control, BY4743-YEplac195 (Wild type). Data presented are pooled from two independent experiments and are expressed as mean +/- range. (C) To quantify the srs2Delta-complementing activity of SGS1 in liquid media, strains were grown up before addition of MMS for 60 min. MMS was then inactivated, washed off and yeast spread on solid media plates. The number of colonies visible after 3 days was then counted on each plate. For each strain, percent viability was expressed as a percentage of viable colonies obtained for the control (no MMS) samples. The diploid strains compared were srs2Delta-YEplac195 (srs2Delta), srs2Delta-YEplac195-SGS1 (srs2Delta-SGS1+) and the isogenic wild-type control, BY4743-YEplac195 (Wild type). Data presented are pooled from two independent experiments and are expressed as mean +/- range.
###end p 59
###begin p 60
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 322 323 322 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 520 524 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 808 812 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMS&#8211;</italic>
 Transposon-scanning mutagenesis of SGS1. (A) Bar chart showing frequency and location of in-frame transposon insertions in a non-selected library. The approximate location of transposon insertion was determined for 75 randomly chosen alleles by analysis of restriction endonuclease digests of mutagenised SGS1 plasmids. (B) Bar chart showing frequency and location of in-frame transposon insertions that abolish MMS complementation. Alleles of SGS1 (100) were selected which failed to rescue the MMS sensitivity of the sgs1Delta mutant. Forty-two of these alleles had their location of transposon insertion determined by analytical restriction digest mapping. The approximate positions of regions required for interaction with Top2 and Top3, the helicase domain and a region dispensable for MMS resistance (MMS-) are indicated.
###end p 60
###begin p 61
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 49 53 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 78 79 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 131 135 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 145 149 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 401 402 381 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 423 426 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT</italic>
###xml 426 427 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 447 451 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 461 465 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 506 510 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 515 519 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 593 597 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 599 603 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
###xml 603 604 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 617 621 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 623 627 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 627 628 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 644 648 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 650 653 622 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 659 663 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 665 668 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">706</sup>
###xml 672 673 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
 Complementation of srs2Delta MMS sensitivity by SGS1 is ploidy independent. (A) MMS sensitivity of haploid and diploid wild-type, sgs1Delta and srs2Delta strains. Strains transformed with the empty YEplac195 vector were grown up, diluted and spotted out onto plates +/- MMS. Plates were left at 30degreesC for 3 days. Cell spots (from left to right) correspond to serial 1 in 10 dilutions of cells. (B) MMS sensitivity of MATa haploid wild-type, sgs1Delta and srs2Delta strains transformed with high-copy SGS1 and SRS2 plasmids. Each strain was transformed with YEplac195 (vector), YEplac195-SRS2 (SRS2+), YEplac195-SGS1 (SGS1+) and YEplac195-SGS1 K706-->A (SGS1 K706-->A+). Strains were grown up in minimal media, then diluted and serially spotted out onto control (no MMS) plates and plates containing 0.01% MMS. Plates were left at 30degreesC for 3 days. Cell spots (from left to right) correspond to serial 1 in 10 dilutions of cells.
###end p 61
###begin p 62
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 85 89 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 154 158 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 598 599 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 610 614 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 631 635 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 667 668 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 679 683 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 699 703 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 705 709 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 715 719 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 719 720 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 436 441 <span type="species:ncbi:4932">yeast</span>
 Effect of multicopy SGS1 on the short lifespan of the srs2Delta mutant. The diploid srs2Delta mutant strain was transformed with YEplac195 and YEplac195-SGS1 and the replicative lifespan determined manually by micromanipulation. Individual cells were followed until they ceased dividing, and replicative age was defined as the number of buds removed from a mother cell. The survivorship curve shows the percentage of the population of yeast cells that are viable plotted against replicative age. Average lifespan of the strains (expressed as mean number of buds removed +/- SEM) was 11.1 +/- 1.2 (n = 37) for srs2Delta-YEplac195 (srs2Delta-vector) and 13.3 +/- 1.4 (n = 38) for srs2Delta-YEplac195-SGS1 (srs2Delta-SGS1+). Maximum lifespans recorded were 24 and 36, respectively.
###end p 62
###begin p 63
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 477 481 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
 Model of Sgs1 and Srs2 function in maintaining genomic stability. A simplified diagram summarising the likely roles of Sgs1 and Srs2 is presented. It is probable that the short lifespan and genotoxin sensitivity in the srs2Delta mutant is due to unrestrained recombination. If levels of Sgs1 are limiting, the ability to antagonise aberrant recombination and promote conservative homologous recombination may thus be overwhelmed. Therefore, increased levels of Sgs1 may allow srs2Delta mutant cells to deal with this situation. Alternatively, it may be that higher levels of Sgs1 can directly replace Srs2 and process substrates that would normally be dealt with by Srs2.
###end p 63
###begin title 64
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae strains and plasmids used in this study
###end title 64
###begin p 65
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R</sup>
###xml 196 202 196 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 196 202 <span type="species:ncbi:562">E.coli</span>
Yeast strains used in this study, and their genotypes, are shown. Additionally, features of plasmids used are briefly described. All plasmids contain the AmpR selectable marker for propagation in E.coli.
###end p 65
###begin p 66
###xml 1 10 1 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARS1 CEN4</italic>
###xml 55 60 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#181;</italic>
*ARS1 CEN4 plasmids are single-copy plasmids, whereas 2micro ori plasmids are multicopy plasmids.
###end p 66
###begin title 67
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sgs1</italic>
###xml 84 88 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">srs2</italic>
###xml 97 101 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pif1</italic>
Ability of various plasmids to rescue the MMS sensitivity of the diploid sgs1Delta, srs2Delta or pif1Delta strains
###end title 67
###begin p 68
###xml 22 27 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#181;</italic>
###xml 257 261 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 305 309 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD3</italic>
All vectors used are 2micro-based high-copy plasmids. The YEplac195 and YEp24 plasmids possess the genes of interest under the control of their own endogenous promoter. The pYES2-based vectors contain the gene of interest under the control of the inducible GAL1 promoter. The pNF3000 plasmid contains the RAD3 gene under control of its own endogenous promoter. Ability to rescue MMS sensitivity is defined as clearly increased colony growth relative to an empty vector control. +, rescue; -, no rescue; N.D., not determined.
###end p 68
###begin p 69
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRS2</italic>
*Plasmids grown in raffinose medium, which allows 'leaky' expression from the GAL1 promoter. Strains containing the pYES2-SRS2 plasmid failed to grow in galactose-containing medium.
###end p 69
###begin title 70
ACKNOWLEDGEMENTS
###end title 70
###begin p 71
We gratefully acknowledge Drs Paula Fischaber and Errol Friedberg for the generous gift of the pNF3000 plasmid. This work was supported by the Wellcome Trust in the form of Prize Studentships to H.W.M. and T.J.C.
###end p 71
###begin title 72
REFERENCES
###end title 72

